Related Experiment Videos
Macular ischemia after intravitreal amikacin on patient with intraocular foreign body
Arief Kartasasmita1, Susi Mona1, Erwin Iskandar1
1Faculty of Medicine, Universitas Padjadjaran/Cicendo National Eye Hospital, Bandung, Indonesia.
Abstract:
Background: Although still used in third world countries, amikacin has a harmful effect to be used intravitreally. Purpose: To report macular ischemia after an intravitreal injection of amikacin Methods: A case report regarding a traumatized eye of a 26-year-old man that was injected intravitreally with amikacin due to intraocular foreign body endophthalmitis Results: Angiography and OCT show macular ischemia due to amikacin toxicity. Conclusion: The case reported here is to alert about the potential harmful effect of intravitreally injected amikacin despite its role as an accepted regimen for endohthalmitis cases.
Insights
Intravitreal amikacin injection can cause macular ischemia, a harmful toxic effect. This case report highlights the risks of using amikacin for endophthalmitis, even in developing nations.
Area of Science:
- Ophthalmology
- Toxicology
Background:
- Amikacin is used to treat endophthalmitis, particularly in developing countries.
- Concerns exist regarding the intravitreal toxicity of amikacin.